Accel-Ondansetron ODT 4 & 8 mg: Data integrity concerns with product's bioequivalence data that could lead to incorrect dosing.
Critical priority
What you should do
- 1Return the affected products to your local pharmacy for a replacement, and for proper disposal.
- 2If you are unsure whether your product is affected, check with your pharmacy.
- 3Consult a health care professional if you have used the affected product and you have health concerns.
- 4Report any health product-related side effects or complaints to Health Canada.
- 5Contact the companies if you have questions about their recall:Accel Pharma Inc., by contacting Betty Cory at Accel Quality Assurance by calling 416-271-4775, or by email at bcory@regxia.com
The issue
Product quality
Affected product
Accel-Ondansetron ODT 4 & 8 mg
Where it was sold
Canada (national)Reported in the official notice — confirm there.
Issued by
Health Canada — Drugs and health products
Read the official Government of Canada notice
All recallsRecallGuardian ranks, illustrates and rewrites recalls in plain language. The official notice is authoritative — confirm model numbers, lot codes, dates and remedies there.